Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Study to Determine the Safety and Efficacy of Curcumin in Patients With Oral Mucositis Secondary to Chemotherapy

NCT02300727 is registered in ClinicalTrials.gov with Amy Beres as lead sponsor.

NCT NCT02300727
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02300727 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Study to Determine the Safety and Efficacy of Curcumin in Patients With Oral Mucositis Secondary to Chemotherapy
Lead sponsor
Amy Beres
Phase
Phase 1/2
Overall status
Terminated
Start date
February 28, 2015
Completion date
October 25, 2018
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mucositis